Long-term Rehabilitation Management of Childhood Acute Lymphoblastic Leukemia Survivors
-
摘要:
急性淋巴细胞白血病占儿童白血病的75%~85%，随着诊疗技术的进步，我国儿童ALL长期无事件生存率达70%~80%。因此，ALL患儿远期躯体功能状态和生活质量越来越受到重视。尽管近20年来肿瘤康复在欧美国家发展迅速，但儿童白血病康复的临床干预措施和学术研究方面仍存在诸多不足，我国儿童白血病康复工作更是落后于西方发达国家。本文中，我们描述了一个相对全面的儿童急性淋巴细胞白血病长期生存康复管理框架，以期更好地提高ALL患儿的远期生存质量。
Abstract:Acute lymphoblastic leukemia (ALL) accounts for 75%-85% of the cases of childhood leukemia. As a result of the progress made in diagnosis and treatment, an event-free survival rate of 70%–80% has been reported in our country. Consequently, research should focus on long-term physical function and quality of life of childhood ALL survivors. In the past 20 years, cancer rehabilitation has achieved rapid development in European and American countries, but gaps remain in clinical practice and academic research of rehabilitation for childhood leukemia. Specifically, rehabilitation for childhood leukemia in our country lags behind, compared with that in Western developed countries. In this commentary, we describe a relatively comprehensive childhood ALL survivorship care quality framework to improve patients' long-term quality of life.
-
Key words:
- Acute lymphoblastic leukemia /
- Children /
- Quality of life /
- Rehabilitation
-
Competing interests: The authors declare that they have no competing interests.作者贡献：陈福宜：资料收集、文章撰写吴婕翎、马廉：资料获取、分析指导文章修改
-
[1] Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001-10: a population-based registry study[J]. Lancet Oncol, 2017, 18(6): 719-731. doi: 10.1016/S1470-2045(17)30186-9
[2] 郑胡镛. 从北京儿童医院看儿童白血病治疗的发展[J]. 中国小儿血液与肿瘤杂志, 2019, 24(6): 282. doi: 10.3969/j.issn.1673-5323.2019.06.002 Zheng HY. The development of childhood leukemia treatment see from Beijing Children's Hospital[J]. Zhongguo Xiao Er Xue Ye Yu Zhong Liu Za Zhi, 2019, 24(6): 282. doi: 10.3969/j.issn.1673-5323.2019.06.002
[3] 中华医学会儿科学分会血液学组, 《中华儿科杂志》编辑委员会. 儿童急性淋巴细胞白血病诊疗建议(第四次修订)[J]. 中华儿科杂志, 2014, 52(9): 641-644. doi: 10.3760/cma.j.issn.0578-1310.2014.09.001 Hematology Group, Pediatrics Branch of Chinese Medical Association, Editorial Committee of Chinese Journal of Pediatrics. Suggestions for the diagnosis and treatment of pediatric acute lymphoblastic leukemia (Fourth revision)[J]. Zhonghua Er Ke Za Zhi, 2014, 52(9): 641-644. doi: 10.3760/cma.j.issn.0578-1310.2014.09.001
[4] Kızılocak H, Okcu F. Late Effects of Therapy in Childhood Acute Lymphoblastic Leukemia Survivors[J]. Turk J Haematol, 2019, 36(1): 1-11. doi: 10.4274/tjh.galenos.2018.2018.0150
[5] Nekhlyudov L, Ganz PA, Arora NK, et al. Going Beyond Being Lost in Transition: A Decade of Progress in Cancer Survivorship[J]. J Clin Oncol, 2017, 35(18): 1978-1981. doi: 10.1200/JCO.2016.72.1373
[6] Viana MB, Vilela MI. Height deficit during and many years after treatment for acute lymphoblastic leukemia in children: a review[J]. Pediatr Blood Cancer, 2008, 50(2 Suppl): 509-516. doi: 10.1002/pbc.21396
[7] Mostoufi-Moab S, Ginsberg JP, Bunin N, et al. Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation[J]. J Bone Miner Res, 2012, 27(4): 760-769. doi: 10.1002/jbmr.1499
[8] 中国临床肿瘤学会, 中华医学会血液学分会. 蒽环类药物心脏毒性防治指南(2013年版)[J]. 临床肿瘤学杂志, 2013, 18(10): 925-934. doi: 10.3969/j.issn.1009-0460.2013.10.014 Chinese Society of Clinical Oncology, The Hematology Branch of the Chinese Medical Association, Guidelines for preventing and controlling cardiotoxicity against anthracyclines (2013 Edition)[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2013, 18(10): 925-934. doi: 10.3969/j.issn.1009-0460.2013.10.014
[9] Caru M, Petrykey K, Drouin S, et al. Identification of genetic association between cardiorespiratory fitness and the trainability genes in childhood acute lymphoblastic leukemia survivors[J]. BMC Cancer, 2019, 19(1): 443. doi: 10.1186/s12885-019-5651-z
[10] Nishi Y, Hamamoto K, Fujita N, et al. Empty sella/pituitary atrophy and endocrine impairments as a consequence of radiation and chemotherapy in long-term survivors of childhood leukemia[J]. Int J Hematol, 2011, 94(4): 399-402. doi: 10.1007/s12185-011-0939-z
[11] Follin C, Erfurth EM. Long-Term Effect of Cranial Radiotherapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors[J]. Curr Treat Options Oncol, 2016, 17(9): 50. doi: 10.1007/s11864-016-0426-0
[12] Inskip PD, Veiga LHS, Brenner AV, et al. Hypothyroidism after Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study[J]. Radiat Res, 2018, 190(2): 117-132. doi: 10.1667/RR14888.1
[13] Inskip PD, Veiga LHS, Brenner AV, et al. Hyperthyroidism After Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study[J]. Int J Radiat Oncol Biol Phys, 2019, 104(2): 415-424. doi: 10.1016/j.ijrobp.2019.02.009
[14] Meistrich ML. Effects of chemotherapy and radiotherapy on spermatogenesis in humans[J]. Fertil Steril, 2013, 100(5): 1180-1186. doi: 10.1016/j.fertnstert.2013.08.010
[15] Green DM, Liu W, Kutteh WH, et al. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study[J]. Lancet Oncol, 2014, 15(11): 1215-1223. doi: 10.1016/S1470-2045(14)70408-5
[16] Burns KC, Hoefgen H, Strine A, et al. Fertility preservation options in pediatric and adolescent patients with cancer[J]. Cancer, 2018, 124(9): 1867-1876. doi: 10.1002/cncr.31255
[17] Michailov Y, Lunenfeld E, Kapilushnik J, et al. Acute Myeloid Leukemia Affects Mouse Sperm Parameters, Spontaneous Acrosome Reaction, and Fertility Capacity[J]. Int J Mol Sci, 2019, 20(1): 219. doi: 10.3390/ijms20010219
[18] Mohn A, Di Marzio A, Capanna R, et al. Persistence of impaired pancreatic beta-cell function in children treated for acute lymphoblastic leukaemia[J]. Lancet, 2004, 363(9403): 127-128. doi: 10.1016/S0140-6736(03)15264-6
[19] Aisyi M, Andriastuti M, Kurniati N. The Effect of Combination of Steroid and L-Asparaginase on Hyperglycemia in Children with Acute Lymphoblastic Leukemia (ALL)[J]. Asian Pac J Cancer Prev, 2019, 20(9): 2619-2624. doi: 10.31557/APJCP.2019.20.9.2619
[20] Zhang FF, Kelly MJ, Saltzman E, et al. Obesity in pediatric ALL survivors: a meta-analysis[J]. Pediatrics, 2014, 133(3): e704-715. doi: 10.1542/peds.2013-3332
[21] Ahn MB, Suh BK. Bone morbidity in pediatric acute lymphoblastic leukemia[J]. Ann Pediatr Endocrinol Metab, 2020, 25(1): 1-9. doi: 10.6065/apem.2020.25.1.1
[22] Velentza L, Zaman F, Sävendahl L. Bone health in glucocorticoid-treated childhood acute lymphoblastic leukemia[J]. Crit Rev Oncol Hematol, 2021, 168: 103492. doi: 10.1016/j.critrevonc.2021.103492
[23] Tay CG, Lee VWM, Ong LC, et al. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia[J]. Pediatr Blood Cancer, 2017, 64(8). doi: 10.1002/pbc.26471
[24] Krull KR, Brinkman TM, Li C, et al. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study[J]. J Clin Oncol, 2013, 31(35): 4407-4415. doi: 10.1200/JCO.2012.48.2315
[25] Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia[J]. Arch Clin Neuropsychol, 2000, 15(7): 603-630. doi: 10.1093/arclin/15.7.603
[26] Luo XJ, Peng J, Li YJ. Recent advances in the study on capsaicinoids and capsinoids[J]. Eur J Pharmacol, 2011, 650(1): 1-7. doi: 10.1016/j.ejphar.2010.09.074
[27] Robison LL. Late effects of acute lymphoblastic leukemia therapy in patients diagnosed at 0-20 years of age[J]. Hematology Am Soc Hematol Educ Program, 2011, 2011: 238-242. doi: 10.1182/asheducation-2011.1.238
[28] 王紫娟, 莫霖, 刘洋, 等. 我国不同年龄阶段白血病儿童生存质量评价量表的初步研制[J]. 护理学杂志, 2016, 31(9): 24-27. doi: 10.3870/j.issn.1001-4152.2016.09.024 Wang ZJ, Mo L, Liu Y, et al. Preliminary development of quality of life scale for leukemia children at different ages[J]. Hu Li Xue Za Zhi, 2016, 31(9): 24-27. doi: 10.3870/j.issn.1001-4152.2016.09.024
[29] Rose SR, Carlsson M, Grimberg A, et al. Response to GH Treatment After Radiation Therapy Depends on Location of Irradiation[J]. J Clin Endocrinol Metab, 2020, 105(10): e3730-e3741. doi: 10.1210/clinem/dgaa478
[30] 潘慧, 班博, 于萍, 等. 从临床诊疗指南及专家共识角度看重组人生长激素治疗的规范化应用[J]. 中华诊断学电子杂志, 2014, 2(2): 85-89. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDDZ201402002.htm Pan H, Ban B, Yu P, et al. The standardized application of rhGH therapy from the perspective of clinical diagnosis and treatment guidelines and expert consensus[J]. Zhonghua Zhen Duan Xue Dian Zi Za Zhi, 2014, 2(2): 85-89. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDDZ201402002.htm
[31] 冯一, 洪莉. 血液肿瘤患儿营养支持[J]. 中国实用儿科杂志, 2011, 26(3): 167-171. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201103006.htm Feng Y, Hong L. Nutritional support for children with hematological tumors[J]. Zhongguo Shi Yong Er Ke Za Zhi, 2011, 26(3): 167-171. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201103006.htm
[32] Hooke MC, Garwick AW, Gross CR. Fatigue and physical performance in children and adolescents receiving chemotherapy[J]. Oncol Nurs Forum, 2011, 38(6): 649-657. doi: 10.1188/11.ONF.649-657
[33] Haddy TB, Mosher RB, Reaman GH. Late effects in long-term survivors after treatment for childhood acute leukemia[J]. Clin Pediatr (Phila), 2009, 48(6): 601-608. doi: 10.1177/0009922809332680
计量
- 文章访问数: 2151
- HTML全文浏览量: 421
- PDF下载量: 165
下载:
